4Kscore Using Serum Stored Uncentrifuged
Completed
Conditions studied: Prostate Cancer
In brief
The purpose of the study is to evaluate whether storage of serum uncentrifuged is an allowable preanalytical procedure
Key facts
- Study ID
- NCT04130776
- Run by
- OPKO Health, Inc.
- People needed
- 64
- Starts
- 2017-10-04
- Expected to finish
- 2018-10-31
- Last updated by the study team
- 2019-10-17
Who can join
Age: 40 and older, up to 80. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Men capable of donating five 5 mL tubes of whole blood
- 40 to 80 years old
- No prior diagnosis of prostate cancer; prior negative prostate biopsy included
- Total PSA (tPSA) value measured within last year to be: at 1.5 ng/mL to 4 ng/mL, 4.1 ng/mL to 10 ng/mL and 10 ng/mL and above
You may not qualify if…
- In the previous 96 hours (4 days), underwent a digital rectal exam
- Any invasive urologic procedure in the 6 months prior to study participation
- Underwent any procedure to treat symptomatic benign prostatic hyperplasia in the last 6 months
- Radical prostatectomy since tPSA measurement
- Received within the previous 6 months 5-alpha reductase inhibitor (5-ARI) therapy such as Avodart (dutasteride) or Proscar (finasteride)
Where it is running
- Sidney Kimmel Cancer Center at Thomas Jefferson University — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.